An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect (PBA) in dementia, stroke and traumatic brain injury: Prism ii combined cohort results for patients aged ≥65 years

Authors
Category Primary study
JournalAmerican Journal of Geriatric Psychiatry
Year 2016
This article has no abstract
Epistemonikos ID: 3c606e44ef914e5a00fc413c7612a8304cf0bd6d
First added on: Feb 08, 2025